The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Germline variants in non-BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival.
 
Ryan M. Kahn
No Relationships to Disclose
 
Pier Selenica
No Relationships to Disclose
 
Thomas Boerner
No Relationships to Disclose
 
Yonghong Xiao
No Relationships to Disclose
 
Tiffany Sia
No Relationships to Disclose
 
Margaret Sheehan
No Relationships to Disclose
 
Qin Zhou
No Relationships to Disclose
 
Alexia Iasonos
Stock and Other Ownership Interests - Bristol-Myers Squibb/Sanofi
Consulting or Advisory Role - Intelligencia; Mirati Therapeutics
 
Rachel N. Grisham
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Corcept Therapeutics; GlaxoSmithKline; GlaxoSmithKline; Intellisphere; Myriad Genetics; Signatera; SpringWorks Therapeutics; Verastem
Research Funding - Bayer (Inst); Context Therapeutics (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); SpringWorks Therapeutics (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - EMD Serono
Other Relationship - Aptitude Health; Cardinal Health; MCM Education; OncLive; Prime Oncology
(OPTIONAL) Uncompensated Relationships - Verastem
 
Roisin Eilish O'Cearbhaill
Honoraria - Curio Science; GlaxoSmithKline; MJH Life Sciences; MJH/PER
Consulting or Advisory Role - Aptitude Health; Bayer; Carina Biotech; Fresenius Kabi; GlaxoSmithKline; GOG Foundation; Immunogen; R-Pharm; Regeneron; Seagan
Research Funding - Acrivon Therapeutics (Inst); AstraZeneca/Merck (Inst); Atara Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Genmab (Inst); GlaxoSmithKline (Inst); GOG Foundation (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Ludwig Institute for Cancer Research (Inst); Merck/Genentech (Inst); Regeneron (Inst); Sellas Life Sciences (Inst); Syndax (Inst); TapImmune Inc. (Inst); TCR2 Therapeutics (Inst)
Travel, Accommodations, Expenses - Gathering Around Cancer; Hitech Health; Society of Gynecologic Oncology
Other Relationship - JAMA Oncology
(OPTIONAL) Uncompensated Relationships - Children's Medical Research Foundation (CMRF)
 
Kara Long
No Relationships to Disclose
 
Dennis S Chi
Stock and Other Ownership Interests - BioNTech; Doximity; Moderna Therapeutics
Consulting or Advisory Role - Apyx Medical; Biom'up; Verthermia
Speakers' Bureau - AstraZeneca; Biom'up
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Genentech/Roche (I); Gyroscope (I); Neurogene (I); Optos (I); Outlook Therapeutics (I); Regeneron (I); Regenxbio (I)
 
Kenneth Offit
Patents, Royalties, Other Intellectual Property - Patent pending on therapeutic applications of targeting ERCC3 mutations in cancer. Diagnosis & treatment of ercc3-mutant cancer US20210137850A1
Other Relationship - AnaNeo Therapeutics
 
Carol Aghajanian
Consulting or Advisory Role - AstraZeneca/Merck; Eisai; Repare Therapeutics
Research Funding - Abbvie (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst)
 
Paul Sabbatini
Honoraria - UpToDate
Research Funding - Bristol-Myers Squibb (Inst); Ludwig Institute for Cancer Research (Inst)
 
Diana Mandelker
No Relationships to Disclose
 
Dmitriy Zamarin
Stock and Other Ownership Interests - Accurius; Calidi Biotherapeutics; ImmunOs Therapeutics
Consulting or Advisory Role - AstraZeneca; Celldex; Crown Bioscience; Genentech/Roche; GlaxoSmithKline; Hookipa Biotech; Memgen; Synthekine; Targovax; Tessa Therapeutics; Xencor
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Plexxikon (Inst); Synthekine (Inst)
Patents, Royalties, Other Intellectual Property - I hold a patent regarding the use of recombinant Newcastle Disease Virus (NDV) for cancer therapy. (Inst)
 
Britta Weigelt
Stock and Other Ownership Interests - Repare Therapeutics (I)
Consulting or Advisory Role - Bain Capital Life Sciences (I); Goldman Sachs (I); PAIGE (I); Repare Therapeutics (I); SAGA Diagnostics (I); Volition RX (I)
Research Funding - Repare Therapeutics
 
Ying L Liu
Research Funding - AstraZeneca (Inst); Repare Therapeutics (Inst); Tesaro/GSK (Inst)
Travel, Accommodations, Expenses - AstraZeneca